Inhibition of phosphodiesterase-4 promotes oligodendrocyte precursor cell differentiation and enhances CNS remyelination

The increasing effectiveness of new disease-modifying drugs that suppress disease activity in multiple sclerosis has opened up opportunities for regenerative medicines that enhance remyelination and potentially slow disease progression. Although several new targets for therapeutic enhancement of rem...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Syed, Yasir A, Baer, Alexandra, Hofer, Matthias P, González, Ginez A, Rundle, Jon, Myrta, Szymon, Huang, Jeffrey K, Zhao, Chao, Rossner, Moritz J, Trotter, Matthew W B, Lubec, Gert, Franklin, Robin J M, Kotter, Mark R
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons 2013
Matèries:
Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3914530/
https://ncbi.nlm.nih.gov/pubmed/24293318
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/emmm.201303123
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars